VéDA BIOSCIENCES
Véda Biosciences is a company that operates in the biotechnology industry. The core focus of the company is the research and development of novel, cannabinoid derived medicines. They have a product line that includes Brain Care, which is likely a product developed from their research. With a team of 11 employees, they are dedicated to the exploration and development of these unique biotechnological solutions. Their work contributes to the advancement of the biotechnology field, particularly in the area of cannabinoid derived medicines.
VéDA BIOSCIENCES
Social Links:
Industry:
Manufacturing Medical Pharmaceutical
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.veda-biosciences.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Arpida AG
Arpida AG is a biopharmaceutical company that focused on the discovery and development of novel products.
PNK Farmaceutici
PNK Farmaceutici is a manufacturing company that specializes in the research and development of dietary supplements and pharmaceuticals.
Roche Diagnostics Belgium
Roche Diagnostics Belgium is a biotechnology company focused on the research and development of pharmaceuticals and diagnostics.
The Armour Group
The Armour Group is a pharmaceutical company that develops and distributes a wide range of cannabis-based medicine products.
Official Site Inspections
http://www.veda-biosciences.com
- Host name: 172.67.202.166
- IP address: 172.67.202.166
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Véda Biosciences"
veda-biosciences.com - We are Véda.
Véda Biosciences' collective regulatory experience helps life sciences companies to mitigate the risks associated with regulatory pathways and to avoid costly delays in bringing solutions to market. Our team's expert, multi-layered …See details»
About Us - VedaBio
Prior to joining the team, Maurice served as Chief Scientific Officer at Sherlock Biosciences, and earlier as Vice President of Global R&D at Thermo Fisher Scientific’s Genetic Sciences …See details»
Véda Biosciences - Crunchbase Company Profile & Funding
Véda Biosciences is a company that operates in the biotechnology industry. The core focus of the company is the research and development of novel, cannabinoid derived medicines. They …See details»
VedaBio
Unlocking the true power of CRISPR for molecular detection. Our platform enables ultra-rapid molecular detection without the need for target amplification.See details»
Véda Biosciences Overview | SignalHire Company Profile
Based in the United Kingdom, Véda Biosciences provides clients across a broad spectrum of industries with bespoke, cannabis-derived products – formulated to their exact requirements. …See details»
Veda Trials
Veda Trials empowers local providers to run high-quality clinical trials in their clinics—delivering transformative treatments to the broadest population as quickly as possible while maintaining …See details»
VÉDA BIOSCIENCES LIMITED overview - Companies House
More for VÉDA BIOSCIENCES LIMITED (11767185) Registered office address 85 Great Portland Street, London, United Kingdom, W1W 7LT . Company status Active Company type Private …See details»
Véda Biosciences - LinkedIn
Véda Biosciences Biotechnology Research London, London 11 followers Cultivating and producing cannabinoids to the exact specifications of our clients.See details»
Véda Biosciences Ltd. - Drug pipelines, Patents, Clinical trials
Explore Véda Biosciences Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Véda Biosciences - Crunchbase
Véda Biosciences is a biotechnology company focused on the research and development of cannabinoid derived medicines. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
VedaBio - Crunchbase Company Profile & Funding
Oct 17, 2023 VedaBio may be growing as it has successfully launched with a significant amount of funding, specifically over forty million dollars, which is indicative of strong financial backing …See details»
Veda Biosciences - 2025 Company Profile - Tracxn
Mar 13, 2025 Veda Biosciences is an unfunded company based in London (United Kingdom), founded in 2018. It operates as a Developer of cannabinoid derived medicines. Veda …See details»
VedaBio Strengthens Management Team
Maurice Exner, PhD, brings more than two decades of experience in global research and development leadership and strategy to VedaBio. Prior to joining the team, Maurice served as …See details»
VÉDA BIOSCIENCES LIMITED
Company Title: VÉDA BIOSCIENCES LIMITED. Domicile: England & Wales. Type: Private, ltd by shares. Formed: 2019-01-15. Status: Active. Incorporation Number: 11767185. Last Check On …See details»
New CRISPR diagnostic player VedaBio emerges with $40M start
Oct 17, 2023 Sherlock Biosciences unearths $80M to bring CRISPR-based tests into the home. VedaBio has also tapped Frédéric Sweeney, venture partner at OMX, to serve as board …See details»
VedaBio Launches with Over $40 Million to Revolutionize
Oct 17, 2023 SAN DIEGO--(BUSINESS WIRE)-- VedaBio, the biotechnology company leading a paradigm-shift in molecular detection, today launched with initial funding of over $40 million …See details»
veda-biosciences.com Reviews | scam, legit or safe check
Check veda-biosciences.com with our free review tool and find out if veda-biosciences.com is legit and reliable. Need advice? Report scams Check Scamadviser! Report a Scam Help & Info API …See details»
Véda Biosciences - Tech Stack, Apps, Patents & Trademarks
Véda Biosciences is a biotechnology company focused on the research and development of cannabinoid derived medicines. New. Resources. Advanced Search ... Experience the new …See details»
VedaBio emerges from stealth with $40m for CRISPR-driven …
Oct 18, 2023 The CRISPR-enabled molecular detection space saw significant attention when Mammoth Biosciences was given an early use authorisation by the US Food and Drug …See details»
VedaBio
Story Highlights. Unveils breakthrough CRISPR CascadeTM platform; Platform delivers best-in-class accuracy without need for target amplification, resulting in analytical turnaround time of < …See details»